Deane Leader currently serves as the Director of the Payer Account Executive Team for the East region at Jazz Pharmaceuticals, where he leverages nearly two decades of expertise in managed care, health outcomes, and market access. In this pivotal role, Deane is responsible for leading...
Deane Leader currently serves as the Director of the Payer Account Executive Team for the East region at Jazz Pharmaceuticals, where he leverages nearly two decades of expertise in managed care, health outcomes, and market access. In this pivotal role, Deane is responsible for leading a dynamic team that strategically positions Jazz's innovative therapies within the competitive landscape of national and regional payers and pharmacy benefit managers (PBMs). His focus spans across critical therapeutic areas, including the company’s Emerging Markets Division (EMD), Neuroscience, and Oncology business units, ensuring that Jazz’s products not only meet the clinical needs of patients but also align with the financial and operational goals of payers.
Deane’s extensive background in real-world evidence (RWE) and health economics and outcomes research (HEOR) enables him to craft compelling value propositions that resonate with stakeholders. By connecting commercial and clinical perspectives, he develops robust strategies that enhance market access potential and profitability across diverse market segments. His previous management of the UnitedHealthcare/Optum account exemplifies his commitment to ensuring patient access to Jazz’s innovative treatments, demonstrating his ability to navigate complex formulary contracting processes effectively.
A skilled negotiator and strategist, Deane excels in competitive analysis and financial assessment, driving cross-functional collaboration to support sales initiatives and product distribution. His leadership not only fosters a high-performing team environment but also cultivates strong relationships with key payer stakeholders, ultimately enhancing the overall market presence of Jazz Pharmaceuticals. As the healthcare landscape continues to evolve, Deane remains at the forefront, championing initiatives that bridge the gap between patient access and payer expectations.
